Caraco Pharmaceutical Laboratories, Ltd. to Announce Third Quarter of Fiscal Year 2009 Results on January 29, 2009
23 January 2009 - 1:24AM
PR Newswire (US)
DETROIT, Jan. 22 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical
Laboratories, Ltd. (NYSE Alternext US: CPD) announced that the
Company intends to release results for its third quarter of fiscal
year 2009, ended December 31, 2008, on Thursday January 29, 2009.
Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops,
manufactures, markets and distributes generic and private-label
pharmaceuticals to the nation's largest wholesalers, distributors,
drugstore chains and managed care providers. Safe Harbor: This news
release contains forward-looking statements made pursuant to the
safe-harbor provisions of the Private Securities Litigation Reform
Act of 1995. Such statements are based on management's current
expectations and are subject to risks and uncertainties that could
cause actual results to differ materially from those described in
the forward-looking statements. These risks and uncertainties are
contained in the Corporation's filings with the Securities and
Exchange Commission and include, but are not limited to:
information of a preliminary nature that may be subject to
adjustment, potentially not obtaining or delay in obtaining FDA
approval for new products, governmental restrictions on the sale of
certain products, development by competitors of new or superior
products or cheaper products or new technology for the production
of products, the entry into the market of new competitors, market
and customer acceptance and demand for new pharmaceutical products,
availability of raw materials, timing and success of product
development and launches, dependence on few products generating
majority of sales, product liability claims for which the Company
may be inadequately insured, and other risks identified in this
report and from time to time in our periodic reports and
registration statements. These forward-looking statements represent
our judgment as of the date of this report. We disclaim, however,
any intent or obligation to update our forward-looking statements.
DATASOURCE: Caraco Pharmaceutical Laboratories, Ltd. CONTACT:
Daniel Movens, +1-313-871-8400, or Tom Versosky, +1-313-556-4150,
both of Caraco Pharmaceutical Web site: http://www.caraco.com/
Copyright